Company · CIK 0000879169 · SIC 8731 — Services-Commercial Physical & Biological Research · Nasdaq

INCYTE CORP · INCY

Insider activity reported against this company. All insider holders · Files at: AGEN, MRUS. On EDGAR ↗

Period1M 3M 6M 1Y 2Y All datashares as filed — not split-adjusted

Open-market activity at this companybuys $275.4M · 12sales $252.1M · 130net $23.2M

Open-market trades as an insider elsewherebuys $60.0M · 1sales $0 · 0net $60.0M

Reported at this company — common stock

Trade	Reported (ET)	Insider	Shares	Avg price	Total	Owned after	Δ stake	Flags
Feb 16, 2016 MForm 4 →	Feb 18, 4:31 pm EST	Reid M HuberEVP, Chief Scientific Officer	5,377	$18.32	$98,507	71,046	—	plan?
Feb 14, 2016 AFForm 4 →	Feb 28, 2017, 4:56 pm EST	Reid M HuberEVP, Chief Scientific Officer	4,188	$121.95	$132,926	54,270	—	plan? late
Feb 12, 2016 PForm 4 →	Feb 16, 8:14 pm EST	Julian Baker +6Director, 10% Owner	887,165	$69.87	$61,983,797	18,958,070	+4.91%	plan?
Feb 11, 2016 PForm 4 →	Feb 16, 8:13 pm EST	Julian Baker +6Director, 10% Owner	2,251,427	$63.53	$143,029,696	18,158,080	+14.2%	plan?
Jan 15, 2016 SForm 4 →	Jan 20, 4:31 pm EST	Paula J SwainEVP, Human Resources	13,531	$76.96	$1,041,346	23,693	−36.4%	plan?
Jan 15, 2016 MForm 4 →	Jan 20, 4:31 pm EST	Paula J SwainEVP, Human Resources	13,531	$3.11	$42,081	37,224	—	plan?
Jan 15, 2016 MForm 4 →	Jan 20, 4:30 pm EST	Eric H. SiegelEVP, General Counsel	2,509	$18.32	$45,965	8,829	—	plan?
Jan 7, 2016 AForm 4 →	Jan 8, 4:40 pm EST	Yao WenqingEVP, Discovery Medicinal and P	2,610	—	—	23,981	—	plan?
Jan 7, 2016 AForm 4 →	Jan 8, 4:39 pm EST	Paul TrowerPrincipal Accounting Officer	822	—	—	8,418	—	plan?
Jan 7, 2016 AForm 4 →	Jan 8, 4:39 pm EST	Paula J SwainEVP, Human Resources	2,610	—	—	23,693	—	plan?
Jan 7, 2016 AForm 4 →	Jan 8, 4:38 pm EST	Eric H. SiegelEVP, General Counsel	2,610	—	—	6,320	—	plan?
Jan 7, 2016 AForm 4 →	Jan 8, 4:37 pm EST	Reid M HuberEVP, Chief Scientific Officer	2,610	—	—	65,669	—	plan?
Jan 7, 2016 AForm 4 →	Jan 8, 4:36 pm EST	Herve HoppenotChairman / CEO, Director	10,442	—	—	360,203	—	plan?
Jan 7, 2016 AForm 4 →	Jan 8, 4:36 pm EST	David W GryskaExecutive Vice President, CFO	2,610	—	—	13,460	—	plan?
Jan 7, 2016 AForm 4 →	Jan 8, 4:35 pm EST	Barry P FlannellyEVP & General Manager US	2,610	—	—	5,632	—	plan?
Jan 6, 2016 SForm 4 →	Jan 8, 4:37 pm EST	Richard S LevyEVP, Chief Drug Dev Officer	3,937	$101.86	$401,023	16,926	−18.9%	plan?
Jan 6, 2016 MForm 4 →	Jan 8, 4:37 pm EST	Richard S LevyEVP, Chief Drug Dev Officer	3,937	$18.32	$72,126	20,863	—	plan?
Dec 31, 2015 AForm 4 →	Jan 5, 2016, 6:22 pm EST	Julian Baker +6Director, 10% Owner	525	$108.45	$56,936	513,020	—	plan?
Dec 31, 2015 FForm 4 →	Dec 31, 4:31 pm EST	Herve HoppenotChairman / CEO, Director	32,297	$109.11	$3,523,926	349,761	—	plan?
Dec 31, 2015 AForm 4 →	Dec 31, 4:30 pm EST	Paul A BrookeDirector	218	$108.45	$23,642	175,466	—	plan?
Dec 31, 2015 AForm 4 →	Dec 31, 4:29 pm EST	Wendy L DixonDirector	149	$108.45	$16,159	7,951	—	plan?
Dec 31, 2015 AForm 4 →	Dec 31, 4:28 pm EST	Jean Jacques BienaimeDirector	133	$108.45	$14,424	391	—	plan?
Dec 10, 2015 SForm 4 →	Dec 14, 4:32 pm EST	Eric H. SiegelEVP, General Counsel	1,936	$107.96	$209,011	3,710	−34.3%	plan?
Dec 10, 2015 MForm 4 →	Dec 14, 4:32 pm EST	Eric H. SiegelEVP, General Counsel	1,936	$18.32	$35,468	5,646	—	plan?
Dec 7, 2015 SForm 4 →	Dec 9, 4:31 pm EST	Richard S LevyEVP, Chief Drug Dev Officer	3,937	$106.18	$418,031	16,926	−18.9%	plan?
Dec 7, 2015 MForm 4 →	Dec 9, 4:31 pm EST	Richard S LevyEVP, Chief Drug Dev Officer	3,937	$18.32	$72,126	20,863	—	plan?
Nov 17, 2015 SForm 4 →	Nov 19, 5:51 pm EST	Paul A FriedmanDirector	225,000	$113.83	$25,612,109	297,518	−43.1%	plan?
Nov 17, 2015 MForm 4 →	Nov 19, 5:51 pm EST	Paul A FriedmanDirector	225,000	$17.79	$4,002,750	422,518	—	plan?
Nov 10, 2015 SForm 4 →	Nov 12, 4:30 pm EST	Eric H. SiegelEVP, General Counsel	2,222	$104.86	$232,999	3,710	−37.5%	plan?
Nov 10, 2015 MForm 4 →	Nov 12, 4:30 pm EST	Eric H. SiegelEVP, General Counsel	2,222	$18.32	$40,707	5,932	—	plan?
Nov 6, 2015 SForm 4 →	Nov 10, 8:21 pm EST	Richard S LevyEVP, Chief Drug Dev Officer	3,936	$116.51	$458,583	16,926	−18.9%	plan?
Nov 6, 2015 MForm 4 →	Nov 10, 8:21 pm EST	Richard S LevyEVP, Chief Drug Dev Officer	3,936	$18.32	$72,108	20,862	—	plan?
Nov 3, 2015 MForm 4 →	Nov 5, 4:47 pm EST	Yao WenqingEVP, Discovery Medicinal and P	5,000	$17.79	$88,950	26,371	—	plan?
Nov 3, 2015 SForm 4 →	Nov 5, 4:47 pm EST	Yao WenqingEVP, Discovery Medicinal and P	5,786	$124.78	$721,961	21,371	−21.3%	plan?
Oct 13, 2015 SForm 4 →	Oct 15, 4:30 pm EDT	Eric H. SiegelEVP, General Counsel	2,222	$101.49	$225,511	3,355	−39.8%	plan?
Oct 13, 2015 MForm 4 →	Oct 15, 4:30 pm EDT	Eric H. SiegelEVP, General Counsel	2,222	$18.32	$40,707	5,577	—	plan?
Oct 6, 2015 SForm 4 →	Oct 8, 4:28 pm EDT	Richard S LevyEVP, Chief Drug Dev Officer	3,937	$122.29	$481,456	16,926	−18.9%	plan?
Oct 6, 2015 MForm 4 →	Oct 8, 4:28 pm EDT	Richard S LevyEVP, Chief Drug Dev Officer	3,937	$18.32	$72,126	20,863	—	plan?
Oct 1, 2015 AForm 4 →	Oct 5, 7:04 pm EDT	Julian Baker +6Director, 10% Owner	516	$110.33	$56,930	512,845	—	plan?
Oct 1, 2015 AForm 4 →	Oct 2, 4:30 pm EDT	Wendy L DixonDirector	147	$110.33	$16,219	7,802	—	plan?
Oct 1, 2015 AForm 4 →	Oct 2, 4:30 pm EDT	Paul A BrookeDirector	215	$110.33	$23,721	175,428	—	plan?
Oct 1, 2015 AForm 4 →	Oct 2, 4:29 pm EDT	Jean Jacques BienaimeDirector	131	$110.33	$14,453	258	—	plan?
Sep 21, 2015 SForm 4 →	Sep 23, 4:35 pm EDT	Reid M HuberEVP, Chief Scientific Officer	10,000	$124.29	$1,242,900	62,865	−13.7%	plan?
Sep 21, 2015 MForm 4 →	Sep 23, 4:35 pm EDT	Reid M HuberEVP, Chief Scientific Officer	10,000	$18.32	$183,200	72,865	—	plan?
Sep 16, 2015 MForm 4 →	Sep 18, 6:33 pm EDT	Julian Baker +6Director, 10% Owner	4,623,926	—	—	512,673	—	plan?
Sep 16, 2015 SForm 4 →	Sep 18, 5:07 pm EDT	Eric H. SiegelEVP, General Counsel	2,222	$130.69	$290,393	3,355	−39.8%	plan?
Sep 16, 2015 MForm 4 →	Sep 18, 5:07 pm EDT	Eric H. SiegelEVP, General Counsel	2,222	$18.32	$40,707	5,577	—	plan?
Sep 11, 2015 SForm 4 →	Sep 15, 4:31 pm EDT	Richard S LevyEVP, Chief Drug Dev Officer	4,301	$130.00	$559,130	16,926	−20.3%	plan?
Sep 8, 2015 SForm 4 →	Sep 10, 4:44 pm EDT	Richard S LevyEVP, Chief Drug Dev Officer	3,937	$118.90	$468,109	21,227	−15.6%	plan?
Sep 8, 2015 MForm 4 →	Sep 10, 4:44 pm EDT	Richard S LevyEVP, Chief Drug Dev Officer	3,937	$18.32	$72,126	25,164	—	plan?
Aug 13, 2015 SForm 4 →	Aug 17, 4:20 pm EDT	Eric H. SiegelEVP, General Counsel	2,222	$107.69	$239,287	3,355	−39.8%	plan?
Aug 13, 2015 MForm 4 →	Aug 17, 4:20 pm EDT	Eric H. SiegelEVP, General Counsel	2,222	$18.32	$40,707	5,577	—	plan?
Aug 7, 2015 MForm 4 →	Aug 10, 4:29 pm EDT	Reid M HuberEVP, Chief Scientific Officer	8,397	$17.92	$150,486	62,857	—	plan?
Aug 6, 2015 SForm 4 →	Aug 10, 4:29 pm EDT	Richard S LevyEVP, Chief Drug Dev Officer	3,936	$111.95	$440,635	21,227	−15.6%	plan?
Aug 6, 2015 MForm 4 →	Aug 10, 4:29 pm EDT	Richard S LevyEVP, Chief Drug Dev Officer	3,936	$18.32	$72,108	25,163	—	plan?
Jul 15, 2015 SForm 4 →	Jul 16, 4:36 pm EDT	Richard S LevyEVP, Chief Drug Dev Officer	70,217	$120.00	$8,426,040	21,227	−76.8%	plan?
Jul 15, 2015 MForm 4 →	Jul 16, 4:36 pm EDT	Richard S LevyEVP, Chief Drug Dev Officer	70,217	$17.79	$1,249,160	91,444	—	plan?
Jul 14, 2015 SForm 4 →	Jul 16, 4:37 pm EDT	Yao WenqingEVP, Discovery Medicinal and P	12,850	$116.70	$1,499,538	21,539	−37.4%	plan?
Jul 14, 2015 MForm 4 →	Jul 16, 4:37 pm EDT	Yao WenqingEVP, Discovery Medicinal and P	12,850	$15.91	$204,502	26,539	—	plan?
Jul 14, 2015 SForm 4 →	Jul 16, 4:37 pm EDT	Eric H. SiegelEVP, General Counsel	2,222	$113.61	$252,441	3,355	−39.8%	plan?
Jul 14, 2015 MForm 4 →	Jul 16, 4:37 pm EDT	Eric H. SiegelEVP, General Counsel	2,222	$18.32	$40,707	5,577	—	plan?
Jul 6, 2015 SForm 4 →	Jul 8, 4:52 pm EDT	Richard S LevyEVP, Chief Drug Dev Officer	3,937	$107.00	$421,259	21,227	−15.6%	plan?
Jul 6, 2015 MForm 4 →	Jul 8, 4:52 pm EDT	Richard S LevyEVP, Chief Drug Dev Officer	3,937	$18.32	$72,126	25,164	—	plan?
Jul 1, 2015 AForm 4 →	Jul 6, 5:40 pm EDT	Julian Baker +6Director, 10% Owner	546	$104.21	$56,899	411,021	—	plan?
Jul 1, 2015 AForm 4 →	Jul 6, 4:29 pm EDT	Wendy L DixonDirector	155	$104.21	$16,153	7,655	—	plan?
Jul 1, 2015 AForm 4 →	Jul 6, 4:28 pm EDT	Paul A BrookeDirector	213	$104.21	$22,197	175,213	—	plan?
Jul 1, 2015 AForm 4 →	Jul 6, 4:28 pm EDT	Jean Jacques BienaimeDirector	127	$104.21	$13,235	127	—	plan?
Jun 23, 2015 SForm 4 →	Jun 25, 4:28 pm EDT	James M DalyEVP, Chief Commercial Officer	11,691	$108.24	$1,265,470	3,521	−76.9%	plan?
Jun 23, 2015 MForm 4 →	Jun 25, 4:28 pm EDT	James M DalyEVP, Chief Commercial Officer	11,691	$21.05	$246,046	4,502	—	plan?
Jun 19, 2015 SForm 4 →	Jun 23, 4:28 pm EDT	Richard S LevyEVP, Chief Drug Dev Officer	20,000	$108.13	$2,162,600	21,227	−48.5%	plan?
Jun 19, 2015 MForm 4 →	Jun 23, 4:28 pm EDT	Richard S LevyEVP, Chief Drug Dev Officer	20,000	$17.79	$355,800	41,227	—	plan?
Jun 12, 2015 SForm 4 →	Jun 16, 4:02 pm EDT	Eric H. SiegelEVP, General Counsel	2,223	$105.31	$234,104	3,355	−39.9%	plan?
Jun 12, 2015 MForm 4 →	Jun 16, 4:02 pm EDT	Eric H. SiegelEVP, General Counsel	2,223	$18.32	$40,725	5,578	—	plan?
Jun 8, 2015 SForm 4 →	Jun 10, 4:43 pm EDT	Richard S LevyEVP, Chief Drug Dev Officer	3,937	$107.58	$423,542	21,227	−15.6%	plan?
Jun 8, 2015 MForm 4 →	Jun 10, 4:43 pm EDT	Richard S LevyEVP, Chief Drug Dev Officer	3,937	$18.32	$72,126	25,164	—	plan?
May 26, 2015 SForm 4 →	May 28, 4:32 pm EDT	Paul A FriedmanDirector	196,751	$107.23	$21,096,678	297,518	−39.8%	plan?
May 26, 2015 MForm 4 →	May 28, 4:32 pm EDT	Paul A FriedmanDirector	196,751	$14.72	$2,896,175	366,650	—	plan?
May 26, 2015 SForm 4 →	May 28, 4:31 pm EDT	James M DalyEVP, Chief Commercial Officer	12,093	$106.40	$1,286,636	3,521	−77.4%	plan?
May 26, 2015 MForm 4 →	May 28, 4:31 pm EDT	James M DalyEVP, Chief Commercial Officer	12,093	$20.90	$252,728	4,502	—	plan?
May 21, 2015 SForm 4 →	May 26, 4:57 pm EDT	Paul A FriedmanDirector	102,243	$108.22	$11,064,921	297,518	−25.6%	plan?
May 21, 2015 MForm 4 →	May 26, 4:57 pm EDT	Paul A FriedmanDirector	102,243	$14.72	$1,505,017	377,110	—	plan?
May 18, 2015 MForm 4 →	May 20, 4:09 pm EDT	Paul A BrookeDirector	20,000	$7.68	$153,600	175,000	—	plan?
May 14, 2015 SForm 4 →	May 15, 4:08 pm EDT	Eric H. SiegelEVP, General Counsel	2,222	$104.99	$233,288	3,355	−39.8%	plan?
May 14, 2015 MForm 4 →	May 15, 4:08 pm EDT	Eric H. SiegelEVP, General Counsel	2,222	$18.32	$40,707	5,577	—	plan?
May 11, 2015 MForm 4 →	May 12, 6:58 pm EDT	Julian Baker +6Director, 10% Owner	60,000	$7.68	$460,800	410,839	—	plan?
May 6, 2015 SForm 4 →	May 8, 4:02 pm EDT	Richard S LevyEVP, Chief Drug Dev Officer	7,412	$99.43	$736,975	21,227	−25.9%	plan?
May 6, 2015 MForm 4 →	May 8, 4:02 pm EDT	Richard S LevyEVP, Chief Drug Dev Officer	7,412	$18.32	$135,788	28,639	—	plan?
Apr 23, 2015 SForm 4 →	Apr 24, 4:20 pm EDT	James M DalyEVP, Chief Commercial Officer	36,941	$107.67	$3,977,437	3,521	−91.3%	plan?
Apr 23, 2015 MForm 4 →	Apr 24, 4:20 pm EDT	James M DalyEVP, Chief Commercial Officer	36,941	$35.97	$1,328,838	18,239	—	plan?
Apr 17, 2015 SForm 4 →	Apr 21, 4:58 pm EDT	Yao WenqingEVP, Discovery Medicinal and P	7,150	$102.04	$729,586	21,539	−24.9%	plan?
Apr 16, 2015 MForm 4 →	Apr 17, 5:10 pm EDT	Reid M HuberEVP, Chief Scientific Officer	10,060	$14.74	$148,286	54,460	—	plan?
Apr 14, 2015 SForm 4 →	Apr 16, 4:29 pm EDT	Eric H. SiegelEVP, General Counsel	2,222	$98.72	$219,356	3,355	−39.8%	plan?
Apr 14, 2015 MForm 4 →	Apr 16, 4:29 pm EDT	Eric H. SiegelEVP, General Counsel	2,222	$18.32	$40,707	4,466	—	plan?
Apr 13, 2015 SForm 4 →	Apr 14, 4:15 pm EDT	Paula J SwainEVP, Human Resources	16,469	$96.29	$1,585,800	21,083	−43.9%	plan?
Apr 13, 2015 MForm 4 →	Apr 14, 4:15 pm EDT	Paula J SwainEVP, Human Resources	16,469	$3.11	$51,219	37,552	—	plan?
Apr 10, 2015 SForm 4 →	Apr 14, 4:14 pm EDT	Yao WenqingEVP, Discovery Medicinal and P	23,000	$95.18	$2,189,250	28,689	−44.5%	plan?
Apr 10, 2015 MForm 4 →	Apr 14, 4:14 pm EDT	Yao WenqingEVP, Discovery Medicinal and P	23,000	$17.79	$409,170	42,689	—	plan?
Apr 7, 2015 SForm 4 →	Apr 8, 4:18 pm EDT	Yao WenqingEVP, Discovery Medicinal and P	20,031	$90.13	$1,805,439	28,689	−41.1%	plan?
Apr 7, 2015 MForm 4 →	Apr 8, 4:18 pm EDT	Yao WenqingEVP, Discovery Medicinal and P	5,000	$17.79	$88,950	48,720	—	plan?
Apr 6, 2015 SForm 4 →	Apr 8, 4:17 pm EDT	Richard S LevyEVP, Chief Drug Dev Officer	25,000	$88.77	$2,219,250	21,227	−54.1%	plan?

Reported at this company — derivatives (options, RSUs, warrants)

Trade	Reported (ET)	Insider	Shares	Avg price	Total	Owned after	Δ stake
Apr 23, 2015 MForm 4 →	Apr 24, 4:20 pm EDT	James M DalyEVP, Chief Commercial Officer	36,941	—	—	19,624	—
Apr 16, 2015 MForm 4 →	Apr 17, 5:10 pm EDT	Reid M HuberEVP, Chief Scientific Officer	10,060	—	—	0	—
Apr 14, 2015 MForm 4 →	Apr 16, 4:29 pm EDT	Eric H. SiegelEVP, General Counsel	2,222	—	—	6,735	—
Apr 13, 2015 MForm 4 →	Apr 14, 4:15 pm EDT	Paula J SwainEVP, Human Resources	16,469	—	—	0	—
Apr 10, 2015 MForm 4 →	Apr 14, 4:14 pm EDT	Yao WenqingEVP, Discovery Medicinal and P	23,000	—	—	35,354	—
Apr 7, 2015 MForm 4 →	Apr 8, 4:18 pm EDT	Yao WenqingEVP, Discovery Medicinal and P	5,000	—	—	58,354	—
Apr 6, 2015 MForm 4 →	Apr 8, 4:17 pm EDT	Richard S LevyEVP, Chief Drug Dev Officer	25,000	—	—	41,782	—
Mar 30, 2015 MForm 4 →	Apr 1, 4:27 pm EDT	Laurent ChardonnetOther	113,776	—	—	0	—
Mar 30, 2015 MForm 4 →	Apr 1, 4:26 pm EDT	Reid M HuberEVP, Chief Scientific Officer	34,263	—	—	0	—
Mar 16, 2015 MForm 4 →	Mar 18, 4:33 pm EDT	Paula J SwainEVP, Human Resources	17,500	—	—	16,469	—
Mar 12, 2015 MForm 4 →	Mar 13, 4:28 pm EDT	Barry A ArikoDirector	80,000	—	—	0	—
Mar 12, 2015 MForm 4 →	Mar 13, 4:27 pm EDT	Eric H. SiegelEVP, General Counsel	2,222	—	—	7,021	—
Mar 10, 2015 MForm 4 →	Mar 10, 5:36 pm EDT	Yao WenqingEVP, Discovery Medicinal and P	4,404	—	—	0	—
Mar 6, 2015 MForm 4 →	Mar 10, 5:13 pm EDT	Richard S LevyEVP, Chief Drug Dev Officer	25,000	—	—	66,782	—
Mar 5, 2015 MForm 4 →	Mar 9, 4:37 pm EDT	Eric H. SiegelEVP, General Counsel	13,333	—	—	7,307	—
Mar 5, 2015 MForm 4 →	Mar 9, 4:35 pm EDT	Richard U De SchutterDirector	40,000	—	—	0	—
Feb 25, 2015 MForm 4 →	Feb 25, 5:29 pm EST	Eric H. SiegelEVP, General Counsel	13,333	—	—	7,593	—
Feb 23, 2015 MForm 4 →	Feb 25, 5:29 pm EST	James M DalyEVP, Chief Commercial Officer	11,112	—	—	4,813	—
Feb 18, 2015 MForm 4 →	Feb 20, 4:43 pm EST	Barry A ArikoDirector	20,000	—	—	0	—
Feb 17, 2015 MForm 4 →	Feb 18, 5:49 pm EST	Richard S LevyEVP, Chief Drug Dev&Medical Of	12,000	—	—	0	—
Feb 17, 2015 MForm 4 →	Feb 18, 5:47 pm EST	Paula J SwainEVP, Human Resources	17,500	—	—	33,969	—
Feb 6, 2015 MForm 4 →	Feb 10, 4:33 pm EST	Richard S LevyEVP, Chief Drug Dev&Medical Of	25,000	—	—	91,782	—
Jan 23, 2015 MForm 4 →	Jan 26, 4:57 pm EST	James M DalyEVP, Chief Commercial Officer	11,109	—	—	30,655	—
Jan 22, 2015 MForm 4 →	Jan 26, 4:57 pm EST	Eric H. SiegelEVP, General Counsel	13,542	—	—	0	—
Jan 20, 2015 AForm 4 →	Jan 22, 4:04 pm EST	Paul J ClancyDirector	30,000	—	—	5,000	—
Jan 20, 2015 AForm 4 →	Jan 22, 4:04 pm EST	Jean Jacques BienaimeDirector	30,000	—	—	5,000	—
Jan 20, 2015 MForm 4 →	Jan 20, 5:28 pm EST	Paula J SwainEVP, Human Resources	17,500	—	—	51,469	—
Jan 16, 2015 MForm 4 →	Jan 20, 5:27 pm EST	Richard S LevyEVP, Chief Drug Dev&Medical Of	12,000	—	—	8,317	—
Jan 8, 2015 MForm 4 →	Jan 12, 5:06 pm EST	Eric H. SiegelEVP, General Counsel	15,626	—	—	0	—
Jan 8, 2015 AForm 4 →	Jan 9, 7:03 pm EST	Yao WenqingEVP, Discovery Medicinal and P	41,545	—	—	1,365	—
Jan 8, 2015 AForm 4 →	Jan 9, 7:02 pm EST	Paula J SwainEVP, Human Resources	21,545	—	—	1,356	—
Jan 8, 2015 AForm 4 →	Jan 9, 7:02 pm EST	Eric H. SiegelEVP, General Counsel	21,545	—	—	1,356	—
Jan 8, 2015 AForm 4 →	Jan 9, 7:01 pm EST	Richard S LevyEVP, Chief Drug Dev&Medical Of	21,545	—	—	1,085	—
Jan 8, 2015 AForm 4 →	Jan 9, 7:01 pm EST	Reid M HuberEVP, Chief Scientific Officer	51,545	—	—	1,365	—
Jan 8, 2015 AForm 4 →	Jan 9, 7:01 pm EST	Herve HoppenotChief Executive Officer, Director	89,771	—	—	1,365	—
Jan 8, 2015 AForm 4 →	Jan 9, 7:00 pm EST	David W GryskaExecutive Vice President, CFO	21,545	—	—	599	—
Jan 8, 2015 AForm 4 →	Jan 9, 7:00 pm EST	Barry P FlannellyEVP, Business Development	21,545	—	—	599	—
Jan 8, 2015 AForm 4 →	Jan 9, 7:00 pm EST	James M DalyEVP, Chief Commercial Officer	21,545	—	—	1,099	—
Jan 8, 2015 AForm 4 →	Jan 9, 6:59 pm EST	Laurent ChardonnetOther	13,984	—	—	1,365	—
Jan 6, 2015 MForm 4 →	Jan 8, 5:34 pm EST	Richard S LevyEVP, Chief Drug Dev&Medical Of	25,000	—	—	116,782	—
Jan 5, 2015 MForm 4 →	Jan 7, 4:29 pm EST	Paula J SwainEVP, Human Resources	17,500	—	—	68,969	—

Filed by this entity as an insider elsewhere — common stock

Trade	Reported (ET)	Company	Shares	Avg price	Total	Owned after	Δ stake	Flags
Feb 14, 2017 PForm 4 →	Feb 14, 5:26 pm EST	AGENUS INCAGEN	10,000,000	$6.00	$60,000,000	17,763,968	+129%	plan?

Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)

No reported derivative activity in this period.